8:00 AM – 8:30 AM
Registration and light breakfast
8:30 AM – 8:40 AM
Introduction
8:40 AM – 9:15 AM
(Keynote) – Vini Mani, Flagship Pioneering & ProFound Therapeutics
Innovating bio-platforms to create first-in-class medicines
9:15 AM – 9:50 AM
David Ciccone, Nimbus Therapeutics
HPGD Inhibition is a Potent Mechanism to Dampen the Autoimmune Response and Restore Intestinal Integrity in Inflammatory Bowel Disease
9:50 AM – 10:25 AM
Caroline Sokol, MGB/HMS
A neuroimmune rheostat driving itch and allergic disease
10:25 AM – 10:45 AM
BREAK
10:45 AM – 11:20 AM
Chloe Jones, GSK
Leveraging encoded technologies for novel binder discovery
11:20 AM – 11:55 AM
Jay Rothstein, Lifordi
Targeted delivery of small molecules and nucleic acids to immune cells using ADCs
11:55 AM – 1:00 PM
BOX LUNCH
1:00 PM – 1:35 PM
Ivan Mascanfroni, Seismic Therapeutic
The promise of machine learning: using Seismic’s IMPACT platform to design IgG cleaving enzymes for chronic treatment of autoimmune diseases
1:35 PM – 2:10 PM
Gabby Dower, Mediar Therapeutic
Anti-WISP1 (MTX-463) as a novel potential therapy for idiopathic pulmonary fibrosis
2:10 PM – 2:30 PM
BREAK
2:30 PM – 3:05 PM
Zaida Ramirez Ortiz, University of Massachusetts Medical School
Exploring the role of Scarf1 in the pathogenesis of autoimmunity
3:05 PM – 3:40PM
Nan Zheng, Nocion Therapeutics
Championing a novel approach to atopic dermatitis therapy through silencing nociceptors with charged sodium channel blockers
3:40 PM – 3:55PM
Closing remarks
4:00 PM – 5:00 PM
Post meeting reception and networking